{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:40:02Z","timestamp":1714059602329},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,8,4]],"date-time":"2000-08-04T00:00:00Z","timestamp":965347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,8,4]],"date-time":"2000-08-04T00:00:00Z","timestamp":965347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/cvm-1-1-015","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Debate: When should we intervene in unstable angina - Time for an old look?"],"prefix":"10.1186","volume":"1","author":[{"given":"Warren K","family":"Laskey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,4]]},"reference":[{"key":"9_CR1","volume-title":"AHCPR Publication No. 94-0602, March","author":"E Braunwald","year":"1994","unstructured":"Braunwald E, Mark DB, Jones RH, Cheitlin MD, Fuster V, McCauley KM: Clinical Practice Guideline No. 10. Unstable angina: diagnosis and management. AHCPR Publication No. 94-0602, March. 1994"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/S0735-1097(98)00140-5","volume":"31","author":"RT van Domburg","year":"1998","unstructured":"van Domburg RT, van Zijl AJ, Veerhoek RJ, Simoons ML: Unstable angina: good long-term outcome after a complicated early course. J Am Coll Cardiol. 1998, 31: 1534-1539. 10.1016\/S0735-1097(98)00140-5.","journal-title":"J Am Coll Cardiol"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis","year":"1983","unstructured":"Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, Lewinter MM, Linares E, Pouget JM, Sab-harwal SC, Chester E, Demots H: Protective effects of aspirin against myocardial infarction and death in men with unstable angina. N Engl J Med . 1983, 309: 396-403.","journal-title":"N Engl J Med"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","volume":"319","author":"P Theroux","year":"1988","unstructured":"Theroux P, Ouimet H, McCans J, Lator JG, Joly P, Levy G, Pelletier E, Juneau M, Stasiak J, deGuise P: Aspirin, heparin or both to treat acute unstable angina. N Engl J Med. 1988, 319: 1105-1111.","journal-title":"N Engl J Med"},{"key":"9_CR5","doi-asserted-by":"crossref","unstructured":"Fragmin and Fast Revascularization During Instability in Coronary Artery Disease Investigators:: Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicenter study. Lancet. 1999, 354: 708-715. 10.1016\/S0140-6736(99)07349-3.","DOI":"10.1016\/S0140-6736(99)07349-3"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","volume":"356","author":"L Wallentin","year":"2000","unstructured":"Wallentin L, Lagerqrest B, Husted S, Kontay F, Stahle E, Swahn E: Outcomes at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: the FRISC II invasive randomized trial. Lancet. 2000, 356: 9-16. 10.1016\/S0140-6736(00)02427-2.","journal-title":"Lancet"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","volume":"26","author":"HV Anderson","year":"1995","unstructured":"Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E: One year results of the TIMI IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator vs. placebo and early invasive vs. conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995, 26: 1643-1650. 10.1016\/0735-1097(95)00404-1.","journal-title":"J Am Coll Cardiol"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1161\/01.CIR.70.3.367","volume":"70","author":"P Ouyang","year":"1984","unstructured":"Ouyang P, Brinker JA, Mellits ED, Weisfeldt ML, Gerstenblith G: Variables predictive of successful medical therapy in patients with unstable angina. Circulation. 1984, 70: 367-376.","journal-title":"Circulation"},{"key":"9_CR9","first-page":"274","volume-title":"In Textbook of Interventional Cardiology, Vol. 1, 2nd edn. Edited by Topol EJ. Philadelphia, PA: WB Saunders,","author":"PJ DeFeyter","year":"1993","unstructured":"DeFeyter PJ, Serruys PW: Percutaneous transluminal coronary angioplasty for unstable angina. In Textbook of Interventional Cardiology, Vol. 1, 2nd edn. Edited by Topol EJ. Philadelphia, PA: WB Saunders,. 1993, 274-291."},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1990","unstructured":"Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med. 1990, 340: 115-126. 10.1056\/NEJM199901143400207.","journal-title":"N Engl J Med"},{"key":"9_CR11","first-page":"1565","volume":"92","author":"PK Shah","year":"1995","unstructured":"Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metelloproteinases and implications for plaque rupture. Circulation. 1995, 92: 1565-1569.","journal-title":"Circulation"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.CIR.97.2.211","volume":"97","author":"EJ Topol","year":"1998","unstructured":"Topol EJ: Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Circulation. 1998, 97: 21-28.","journal-title":"Circulation"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/01.CIR.97.12.1195","volume":"97","author":"P Theroux","year":"1998","unstructured":"Theroux P, Fuster V: Acute coronary syndromes - unstable angina and non-Q wave myocardial infarction. Circulation. 1998, 97: 1195-1206.","journal-title":"Circulation"},{"key":"9_CR14","first-page":"S62","volume":"32 (Suppl 3)","author":"S Kinlay","year":"1998","unstructured":"Kinlay S, Selwyn AP, Libby P, Ganz P: Inflammation, the endothelium and the acute coronary syndromes. J Cardiovasc Pharm . 1998, 32 (Suppl 3): S62-S66.","journal-title":"J Cardiovasc Pharm"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM199408183310701","volume":"331","author":"G Liuzzo","year":"1994","unstructured":"Liuzzo G, Brasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reactive protein and serum amyloid - a protein in severe unstable angina. N Engl J Med. 1994, 331: 417-424. 10.1056\/NEJM199408183310701.","journal-title":"N Engl J Med"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","volume":"31","author":"DA Morrow","year":"1998","unstructured":"Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E: C-Reactive protein is a potent predictor of mortality independent of and in combination with troponin T in acute coronary syndromes: a TIMI 11A sub-study. J Am Coll Cardiol. 1998, 31: 1460-1465. 10.1016\/S0735-1097(98)00136-3.","journal-title":"J Am Coll Cardiol"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E: Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998, 98: 839-844.","journal-title":"Circulation"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","volume":"353","author":"RS Rosenson","year":"1999","unstructured":"Rosenson RS, Tangney CC, Casey CL: Inhibition of pro-inflammatory cytokine production by pravastatin. Lancet. 1999, 353: 983-984. 10.1016\/S0140-6736(99)00564-4.","journal-title":"Lancet"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/0002-9149(90)91348-A","volume":"65","author":"MA Lukas-Laskey","year":"1990","unstructured":"Lukas-Laskey MA, Deutsch E, Barnathan E, Laskey WK: Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris. Am J Cardiol. 1990, 65: 1425-1429.","journal-title":"Am J Cardiol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJM199404073301402","volume":"330","author":"Investigators EPIC","year":"1994","unstructured":"EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high risk coronary angioplasty. N Engl J Med. 1994, 330: 956-961. 10.1056\/NEJM199404073301402.","journal-title":"N Engl J Med"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/01.CIR.98.22.2370","volume":"98","author":"G Liuzzo","year":"1998","unstructured":"Liuzzo G, Buffon A, Biasucci LM, Gallimore R, Caligiuri G, Vitelli A, Altamura S, Ciliberto G, Rebuzzi AG, Crea F, Pepys MB, Maseri A: Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998, 98: 2370-2376.","journal-title":"Circulation"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0735-1097(99)00581-1","volume":"35","author":"A Buffon","year":"2000","unstructured":"Buffon A, Santini SA, Ramazzotti V, Rigattieri S, Liuzzo G, Biasucci LM, Crea F, Biardina B, Maseri A: Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia. J Am Coll Cardiol . 2000, 35: 633-639. 10.1016\/S0735-1097(99)00581-1.","journal-title":"J Am Coll Cardiol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0140-6736(99)90234-9","volume":"353(Suppl II)","author":"V Fuster","year":"1999","unstructured":"Fuster V, Fayad Z, Badimon J: Acute coronary syndromes: biology. Lancet. 1999, 353(Suppl II): 5-9.","journal-title":"Lancet"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/01.CIR.94.7.1528","volume":"94","author":"AE Abdelmeguid","year":"1996","unstructured":"Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG: Significance of mild transient release of creatine kinase - MB fraction after percutaneous coronary intervention. Circulation . 1996, 94: 1528-1536.","journal-title":"Circulation"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0735-1097(97)00506-8","volume":"31","author":"RM Califf","year":"1998","unstructured":"Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman M: Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998, 31: 241-251. 10.1016\/S0735-1097(97)00506-8.","journal-title":"J Am Coll Cardiol"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1161\/01.CIR.98.25.2829","volume":"98","author":"DF Kong","year":"1998","unstructured":"Kong DF, Califf RM, Miller DP, Moliterno DJ, White HD, Harrington RA, Tcheng JE, Lincoff AM, Hasselblad V, Topol EJ: Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb\/IIIa integrin in ischemic heart disease. Circulation. 1998, 98: 2829-2835.","journal-title":"Circulation"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","volume":"38","author":"WE Boden","year":"1998","unstructured":"Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW: Outcomes in patients with acute non-Q-wave myocardial infarction randomly asigned to an invasive as compared with a conservative management approach. N Engl J Med. 1998, 38: 1785-1792. 10.1056\/NEJM199806183382501.","journal-title":"N Engl J Med"},{"key":"9_CR28","doi-asserted-by":"crossref","unstructured":"The CAPTURE Investigators: Randomized, placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 1997, 349: 1429-1435. 10.1016\/S0140-6736(96)10452-9.","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"9_CR29","doi-asserted-by":"crossref","unstructured":"The PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998, 339: 436-443. 10.1056\/NEJM199808133390704.","DOI":"10.1056\/NEJM199808133390704"},{"key":"9_CR30","doi-asserted-by":"crossref","unstructured":"The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Visible Signs and Symptoms (PRISM-PLUS) Study Investigators: Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 1998, 338: 1488-1497. 10.1056\/NEJM199805213382102.","DOI":"10.1056\/NEJM199805213382102"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cvm-1-1-015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cvm-1-1-015\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cvm-1-1-015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T15:07:25Z","timestamp":1714057645000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/cvm-1-1-015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2000,4]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1186\/cvm-1-1-015","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,4]]},"assertion":[{"value":"3 April 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2000","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2000","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2000","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"15"}}